SMTL ID : 6p6d.1

HUMAN IGG1 FC FRAGMENT, C239 INSERTION MUTANT

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.31 Å

Oligo State

homo-dimer

Ligands

2 x NAG- NAG- BMA- MAN- NAG- MAN- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-NAG-MAN-NAG-FUC.1: 13 residues within 4Å: Chain A: F.22, F.24, T.41, V.45, D.46, Q.76, Y.77, N.78, T.80, R.82 Ligands: NAG-NAG-BMA-MAN-NAG-MAN-NAG-FUC.2, NAG-NAG-BMA-MAN-NAG-MAN-NAG-FUC.2, CYS.3 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:Y.77 Hydrogen bonds: A:R.82 NAG-NAG-BMA-MAN-NAG-MAN-NAG-FUC.2: 12 residues within 4Å: Chain B: F.22, F.24, K.27, T.41, V.43, V.45, D.46, Y.77, N.78, R.82 Ligands: NAG-NAG-BMA-MAN-NAG-MAN-NAG-FUC.1, CYS.4 3 PLIP interactions: 3 interactions with chain B Hydrophobic interactions: B:Y.77 Hydrogen bonds: B:K.27, B:K.27, B:T.41

2 x CYS: CYSTEINE(Non-covalent)

CYS.3: 5 residues within 4Å: Chain A: P.18, S.19, C.20, D.46 Ligands: NAG-NAG-BMA-MAN-NAG-MAN-NAG-FUC.1 No protein-ligand interaction detected (PLIP) CYS.4: 3 residues within 4Å: Chain B: C.20, D.46 Ligands: NAG-NAG-BMA-MAN-NAG-MAN-NAG-FUC.2 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gallagher, D.T. et al., Structure and Dynamics of a Site-Specific Labeled Fc Fragment with Altered Effector Functions. Pharmaceutics (2019)

Release Date

2020-04-15

Peptides

IgG1 Fc fragment: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

IgG1 Fc fragment